RANCHO CUCAMONGA, Calif., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Jason Shandell, President and Bill Peters, CFO will be presenting at the 27th Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, 2015 at 11:30 a.m. Eastern Standard Time in New York, NY.
This presentation will be made available with a live webcast and may be accessed by visiting Amphastar's Pharmaceuticals website at http://ir.amphastar.com/events.cfm. This webcast will be available for 90 days following the presentation.
Amphastar is a specialty pharmaceutical company established in 1996 that primarily develops, manufactures, markets, and sells generic and proprietary injectable and inhalation products, including products with high technical barriers to market entry. Most of the Company's products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. We currently produce approximately 16 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. Amphastar's long-standing relationship with the major group purchasing organizations and drug wholesalers in the U.S. enables it to establish significant market share upon the introduction of its new products.
Please visit us online at http://www.amphastar.com/index.html for more Company information.
This press release contains forward-looking statements, including statements relating to Amphastar Pharmaceuticals. These statements are not historical facts but rather are based on Amphastar Pharmaceuticals' current expectations, estimates and projections regarding Amphastar Pharmaceuticals' business, operations and other similar or related factors. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," and other similar or related expressions are used to identify these forward-looking statements. These statements are only predictions and as such are not guarantees of future performance, and they involve risks, uncertainties, and assumptions that are difficult or impossible to predict. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Amphastar Pharmaceuticals' filings with the SEC.
CONTACT: William J. Peters Chief Financial Officer (909) 980-9484Source:Amphastar Pharmaceuticals, Inc.